SEC Form 4
PACS Group, Inc. (PACS) insider trading
In the 12 months to Oct 26, 2026, 6 PACS insiders reported open-market sales of $94.5M across 26 filings; one director bought $500.0K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $94.5M
- 26 filings · 6 insiders
- Open-market purchases
- $500.0K
- 1 filing · Evelyn S. Dilsaver, Director
- Pre-arranged sales (10b5-1)
- 23 of 26
- $88.3M of $94.5M sold (93%)
Who traded PACS, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
PACS daily close from Oct 27, 2025 to Oct 26, 2026, between $10.58 and $48.75, last $48.75. 26 sale and 1 purchase filings by 7 insiders, marked at their filing dates. Mark Hancock, Co Fndr; Exec V Chair → Director: sold $41.0M across 7 filings, first filed Jun 17, 2026, last Sep 15, 2026. Jason Hulse Murray, Co-Founder, CEO & Chairman: sold $35.9M across 9 filings, first filed Aug 19, 2026, last Oct 21, 2026. Joshua Jergensen, President & COO: sold $8.4M across 5 filings, first filed Mar 17, 2026, last Oct 16, 2026. John Todd Mitchell, Chief Legal Officer & Sec.: sold $7.8M across 2 filings, first filed Nov 26, 2025, last May 19, 2026. Michelle Renee Lewis, Chief Accounting Officer: sold $1.3M across 2 filings, first filed Jun 26, 2026, last Jul 6, 2026. Evelyn S. Dilsaver, Director: bought $500.0K across 1 filing, first filed Nov 26, 2025, last Nov 26, 2025. Patrick Hugh Conway, Director: sold $155.3K across 1 filing, first filed Aug 27, 2026, last Aug 27, 2026.
Largest mark · tap a row for others
Jason Hulse Murray · Co-Founder, CEO & Chairman
Filing 1 of 2 within a week · $17,048,867 total
Sale $10,437,434
236,116 shares at $44.20 avg
Filed Aug 19, 2026 · traded Aug 17
Pre-arranged (10b5-1) · close on filing date $44.26
Mark Hancock · Co Fndr; Exec V Chair → Director
Co Fndr; Exec V Chair → Director
$41.0M soldJason Hulse Murray · Co-Founder, CEO & Chairman
Co-Founder, CEO & Chairman
$35.9M soldJoshua Jergensen · President & COO
President & COO
$8.4M soldJohn Todd Mitchell · Chief Legal Officer & Sec.
Chief Legal Officer & Sec.
$7.8M soldMichelle Renee Lewis · Chief Accounting Officer
Chief Accounting Officer
$1.3M soldEvelyn S. Dilsaver · Director
Director
$500.0K boughtPatrick Hugh Conway · Director
Director
$155.3K soldOpen-market trades
27 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Mark Hancock | Co Fndr; Exec V Chair → Director | $41.0M | — | 7 | 100% of sales | |
| Jason Hulse Murray | Co-Founder, CEO & Chairman | $35.9M | — | 9 | 100% of sales | |
| Joshua Jergensen | President & COO | $8.4M | — | 5 | 85% of sales | |
| John Todd Mitchell | Chief Legal Officer & Sec. | $7.8M | — | 2 | 39% of sales | |
| Michelle Renee Lewis | Chief Accounting Officer | $1.3M | — | 2 | 100% of sales | |
| Evelyn S. Dilsaver | Director | — | $500.0K | 1 | — | |
| Patrick Hugh Conway | Director | $155.3K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Jason Hulse Murray Co-Founder, CEO & Chairman | SalePre-arranged (10b5-1) | 45,707 | $47.64 | $2.2M | 54,270,813 | |
traded | Joshua Jergensen President & COO | SalePre-arranged (10b5-1) | 40,000 | $44.50 | $1.8M | 2,456,320 | |
traded | Jason Hulse Murray Co-Founder, CEO & Chairman | SalePre-arranged (10b5-1) | 118,729 | $47.29 | $5.6M | 54,316,520 | |
traded | Jason Hulse Murray Co-Founder, CEO & Chairman | SalePre-arranged (10b5-1) | 36,692 | $43.08 | $1.6M | 54,435,249 | |
traded | Jason Hulse Murray Co-Founder, CEO & Chairman | SalePre-arranged (10b5-1) | 83,308 | $42.00 | $3.5M | 54,471,941 | |
traded | Joshua Jergensen President & COO | SalePre-arranged (10b5-1) | 40,000 | $43.13 | $1.7M | 2,499,818 | |
traded | Mark Hancock Director | SalePre-arranged (10b5-1) | 300,000 | $43.48 | $13.0M | 53,539,968 | |
traded | Jason Hulse Murray Co-Founder, CEO & Chairman | SalePre-arranged (10b5-1) | 19,617 | $45.19 | $886.6K | 54,555,249 | |
traded | Jason Hulse Murray Co-Founder, CEO & Chairman | SalePre-arranged (10b5-1) | 51,887 | $43.12 | $2.2M | 54,574,866 | |
traded | Jason Hulse Murray Co-Founder, CEO & Chairman | SalePre-arranged (10b5-1) | 68,113 | $42.63 | $2.9M | 54,627,611 | |
traded | Patrick Hugh Conway Director | Sale | 3,497 | $44.41 | $155.3K | 8,947 | |
traded | Jason Hulse Murray Co-Founder, CEO & Chairman | SalePre-arranged (10b5-1) | 150,550 | $43.92 | $6.6M | 54,722,456 | |
traded | Jason Hulse Murray Co-Founder, CEO & Chairman | SalePre-arranged (10b5-1) | 236,116 | $44.20 | $10.4M | 54,845,483 | |
traded | Joshua Jergensen President & COO | SalePre-arranged (10b5-1) | 40,000 | $45.59 | $1.8M | 2,572,695 | |
traded | Joshua Jergensen President & COO | SalePre-arranged (10b5-1) | 40,000 | $45.02 | $1.8M | 2,608,880 | |
traded | Mark Hancock Director | SalePre-arranged (10b5-1) | 13,628 | $45.04 | $613.8K | 53,906,884 | |
traded | Mark Hancock Director | SalePre-arranged (10b5-1) | 25,304 | $45.07 | $1.1M | 53,920,512 | |
traded | Michelle Renee Lewis Chief Accounting Officer | SalePre-arranged (10b5-1) | 15,000 | $45.03 | $675.4K | 355,338 | |
traded | Mark Hancock Director | SalePre-arranged (10b5-1) | 161,068 | $45.30 | $7.3M | 53,945,816 | |
traded | Michelle Renee Lewis Chief Accounting Officer | SalePre-arranged (10b5-1) | 15,000 | $40.01 | $600.2K | 370,338 | |
traded | Mark Hancock Co Fndr; Exec V Chair | SalePre-arranged (10b5-1) | 200,000 | $40.38 | $8.1M | 54,102,597 | |
traded | Mark Hancock Co Fndr; Exec V Chair | SalePre-arranged (10b5-1) | 63,680 | $35.31 | $2.2M | 54,302,597 | |
traded | Mark Hancock Co Fndr; Exec V Chair | SalePre-arranged (10b5-1) | 236,320 | $36.18 | $8.6M | 54,366,277 | |
traded | John Todd Mitchell Chief Legal Officer & Sec. | SalePre-arranged (10b5-1) | 80,152 | $37.72 | $3.0M | 806,866 | |
traded | Joshua Jergensen President & COO | Sale | 36,335 | $34.28 | $1.2M | 2,667,347 | |
traded | Evelyn S. Dilsaver Director | Purchase | 16,724 | $29.90 | $500.0K | 22,739 | |
traded | John Todd Mitchell Chief Legal Officer & Sec. | Sale | 159,556 | $29.89 | $4.8M | 755,836 |
GET /stocks/filings/vX/form-4?tickers=PACS&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"PACS"
],
"issuer_cik": "0002001184",
"owner_cik": "0002014386",
"accession_number": "0002014386-26-000022",
"form_type": "4",
"filing_date": "2026-10-21",
"period_of_report": "2026-10-19",
"issuer_name": "PACS Group, Inc.",
"issuer_trading_symbol": "PACS",
"owner_name": "Murray Jason Hulse",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "Co-Founder, CEO & Chairman",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-21",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 6610,
"transaction_price_per_share": 47.618,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 54270813,
"transaction_value": 314754.98000000004,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026."
},
{
"id": "F4",
"description": "The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.50 to $47.82 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
}
]
},
{
"tickers": [
"PACS"
],
"issuer_cik": "0002001184",
"owner_cik": "0002014386",
"accession_number": "0002014386-26-000022",
"form_type": "4",
"filing_date": "2026-10-21",
"period_of_report": "2026-10-19",
"issuer_name": "PACS Group, Inc.",
"issuer_trading_symbol": "PACS",
"owner_name": "Murray Jason Hulse",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "Co-Founder, CEO & Chairman",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-20",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 37477,
"transaction_price_per_share": 47.6511,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 54277423,
"transaction_value": 1785820.2747,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026."
},
{
"id": "F3",
"description": "The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.50 to $47.835 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 43 records
- Tax withholding8 records
- Grants and awards33 records
- Gifts2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Role
- The title on each filing. Someone whose title changed shows more than one.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has PACS Group, Inc.'s CEO sold stock?
Yes. Jason Hulse Murray (CEO) sold 810,719 shares ($35.9M) between Aug 2026 and Oct 2026, all under a pre-arranged 10b5-1 plan.
How current is PACS’s insider data?
These are PACS Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track PACS insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for PACS every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.